July 22 (Reuters) - Intuitive Surgical ( ISRG ) beat

Wall Street estimates for second-quarter profit and revenue on

Tuesday, driven by growing demand for its surgical robots used

in minimally invasive procedures.

A steady rise in demand for elective surgeries has

contributed to higher procedure volumes for medical device

makers such as Intuitive Surgical ( ISRG ) in recent quarters.

The company, known for its da Vinci robotic systems, has

seen consistent growth as hospitals work through a backlog of

deferred procedures and expand access to minimally invasive

care.

The medical device maker slightly raised its adjusted gross

profit margin forecast for 2025 to between 66% and 67% of

revenue, up from earlier estimates of 65% to 66.5%.

The updated range includes an estimated impact from tariffs

of 1% of revenue, plus or minus 20 basis points, Intuitive said,

compared to previously estimated impact of 1.7% of revenue, plus

or minus 30 basis points.

Shares of the Sunnyvale, California-based company fell 1.5%

in after-hours trading.

More than 80% of the instruments and accessories for the

company's da Vinci system are produced at Intuitive's facility

in Mexico, while the company also operates in China and other

international markets.

Intuitive's worldwide da Vinci procedure volumes rose about

17% compared to the same quarter last year.

The company expects global da Vinci-assisted procedures to

increase by about 15.5% to 17% in 2025, up from its prior

forecast of 15% to 17%.

On an adjusted basis, the medical device maker earned $2.19

per share for the quarter ended June 30, beating analysts'

estimates of $1.92 per share, according to LSEG data.

The company reported revenue of $2.44 billion for the second

quarter, compared to analysts' estimates of $2.35 billion.